ongoing

RADICAL PC1 is a prospective cohort study of men with a new diagnosis of prostate cancer.

The primary objective of RADICAL PC1 is to determine the prevalence of cardiovascular risk factors and disease, and the incidence of major adverse cardiovascular events in men with prostate cancer and in particular men treated with Androgen Deprivation Therapy.

Study Type

Observational

Study Design

Prospective cohort

NO. of Countries

1

NO. of Sites

18

NO. of Participants

6000

Study Period

2015 - 2025

Sponsor

PHRI

Prostate Cancer Canada

Canadian Cancer Society

Hamilton Health Sciences

Darryl Leong presents on CVD risk scoring in prostate cancer patients undergoing hormonal PCa treatment

Back To Top